株式会社NovAccel News Releases

NovAccel Raises 1.2 Billion JPY in Post-Seed Round Funding

NovAccel, a developer of small superconducting accelerators for medical radioisotope production, has… · 2026-05-11

Successful Extraction of Actinium-225 with Radionuclidic Purity Exceeding 99.99%

NovAccel has successfully achieved the extraction of Actinium-225 with over 99.99% purity using thei… · 2026-04-20

Successful Extraction of Actinium-225 with Radionuclidic Purity Exceeding 99.99%

NovAccel has successfully achieved the extraction of Actinium-225 with over 99.99% purity using thei… · 2026-04-20

Successful Extraction of Actinium-225 with Radionuclidic Purity Exceeding 99.99%

NovAccel has successfully achieved the extraction of Actinium-225 with over 99.99% purity using thei… · 2026-04-20

NovAccel Begins Taking Sample Sales Reservations for 'Actinium-225'

NovAccel Inc. will begin a sample supply program for the medical radioisotope 'Actinium-225', essent… · 2026-05-18

NovAccel Begins Taking Sample Sales Reservations for 'Actinium-225'

NovAccel Inc. will begin a sample supply program for the medical radioisotope 'Actinium-225', essent… · 2026-05-18

NovAccel Raises 1.2 Billion JPY in Post-Seed Round Funding

NovAccel, a developer of small superconducting accelerators for medical radioisotope production, has… · 2026-05-11